How does cognition play a role in rare diseases?
Cambridge Cognition's Jemma Clark shares her insight into how cognitive function can be affected in certain rare diseases and why it is important to include cognitive tests in rare disease trials.
CANTAB to enhance cognitive assessment in rare neurological diseases
We caught up with psychologist, Lara Draghi, to discuss the value of using CANTAB to assess cognitive function in patients with rare neurological disorders.
web-based testing, wearables, voice recognition, voice, virtual clinical trials, technology, swm, subjective measures, stress, social cognition, smartphones, schizophrenia, safety, rvp, rti, research funding, research, remote testing, recruitment, psychosis, prodromal, pro-cognitive, prm, press release, presenteeism, precision psychiatry, poster, personalised medicine, patient-centric, patient recruitment, parkinson's disease, pal, ots, occupational health, objective measures, normative data, neuroscience, near-patient testing, multiple sclerosis, mts, ms, mental wellbeing, mental health at work, mental health, mdd, mci, major depression, machine learning, longitudinal, life at cambridge cognition, international women's day, hot cognition, healthcare, grant, funding, fatigue, ert, epidemiology, ecoa, ebt, early career researchers, early alzheimer's disease, dms, digital tools, digital health, depression, dementia, covid-19, cognitive wellbeing, cognitive testing, cognitive science, cognitive safety, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic illness, chronic health conditions, cgt, cantab testimonial, cantab research grant, cantab, cambridge cognition careers, cambridge cognition, brain health, bipolar disorder, biomarkers, automatic speech recognition, attention, alzheimer's disease, academic, absenteeism,